REPL
Replimune Group, Inc. · Healthcare
Director Kapil Dhingra sold $1.8M of Replimune Group, Inc.
Sold$1,822,395
$45.56Price
40,000Shares
−100%Stake
What REPL did after the filing
Prices for REPL after this filing aren't in yet.
Traded Mon, Dec 7. Filed Wed, Dec 9, 7:48 PM ET, after the close. Not investment advice.